Sandoz Ambrisentan Tablets 10 mg (Ambrisentan TABLET) 10 MG

Sandoz Ambrisentan Tablets 10 mg are a pharmaceutical product used to manage certain conditions. This oral medication is designed to support specific therapeutic needs, offering a reliable option for those seeking effective treatment.

Strength

10 MG

Manufacturer / TM Owner

SANDOZ CANADA INCORPORATED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ambrisentan is primarily used to address conditions related to pulmonary arterial hypertension. This medication works by helping to relax the blood vessels in the lungs, which can improve blood flow and reduce symptoms associated with this condition. It is often prescribed as part of a comprehensive treatment plan to manage the effects of pulmonary arterial hypertension.

Side Effects

Common effects of Ambrisentan may include headaches, nausea, and fluid retention. Some individuals might experience dizziness or fatigue while taking this medication. It is important to monitor any unusual symptoms and consult a healthcare provider if they persist or worsen.

Precautions & Warnings

Ambrisentan should be handled with care, especially for individuals with liver problems or those who are pregnant. It is essential to follow the prescribed dosage and avoid sudden discontinuation without medical advice. Regular monitoring may be required to ensure the medication's safety and effectiveness.

Avoid Interactions

Ambrisentan may interact with certain medications, including other blood pressure treatments and CYP3A4 inhibitors. It is crucial to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare professional.

Frequently Asked Questions

Ambrisentan is used to manage pulmonary arterial hypertension by relaxing blood vessels in the lungs.

Ambrisentan is taken orally, typically once daily, as prescribed by a healthcare provider.

Common side effects may include headaches, nausea, fluid retention, dizziness, and fatigue.

Ambrisentan may interact with other medications, so it is important to consult a healthcare provider before combining treatments.

Ambrisentan should be used with caution during pregnancy, and a healthcare provider should be consulted for personalized advice.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.